Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Hepatocellular × Memantine × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Brain Neoplasms 4 Prostatic Neoplasms 2 Cognitive Dysfunction 2 Breast Neoplasms 2 Tobacco Use Disorder 1 Recurrence 1 Rectal Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Motor Activity 1 Lung Neoplasms 1 Glioblastoma 1 Ependymoma 1 Craniopharyngioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Sorafenib 62 Bevacizumab 59 lenvatinib 52 durvalumab 35 atezolizumab 27 sintilimab 26 Nivolumab 26 pembrolizumab 24 Oxaliplatin 24 tremelimumab 22 tislelizumab 22 Fluorouracil 21 apatinib 20 Radiosurgery 19 camrelizumab 18 regorafenib 15 cabozantinib 15 Doxorubicin 15 Leucovorin 14 Capecitabine 13 Radiotherapy 12 Folfox protocol 12 donafenib 11 Gemcitabine 10 Cisplatin 10 Immune Checkpoint Inhibitors 9 Erlotinib Hydrochloride 9 toripalimab 8 Neoadjuvant Therapy 8 Immunotherapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06789757 2025-10-07

(HCC)

Inova Health Care Services

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡